Supplementary video S3, S4. Fluorescence thoracoscopic imaging after NIR-PIT
Fluorescence thoracoscopic imaging shows intrathoracic tumors and colocalization of GFP and IR700 fluorescence. 100 #g of APC was intravenously injected 1 day before the imaging. S3 Anterior half: GFP fluorescence thoracoscopy imaging of control tumors (received only APC but no NIR-light). S3 Posterior half: IR700 fluorescence thoracoscopy imaging of pleural tumors(received only APC but no light). S4 Anterior half: GFP fluorescence thoracoscopy imaging after NIR-PIT. S4 Posterior half: IR700 fluorescence thoracoscopy imaging after NIR-PIT.
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Specific targeted necrotic cell death was observed after NIR-PIT in vitro.
Calu3-luc-GFP cells were co-cultured with 3T3-RFP (non-HER expressing) cells. They were treated with tra-IR700 and observed (before and after irradiation of NIR light). Target specific necrotic cell death was observed upon excitation with NIR light (after 30 min) on Calu3-luc-GFP cell but not 3T3-RFP cells. *Calu3-luc-GFP cell, Bar = 25 µm. In vitro NIR-PIT was evaluated by FACS using PI staining. Calu3-luc-GFP cells were incubated with or without the addition of 1,000 µg/mL trastuzumab for 1 hr, then added 10 µg/mL Tra-IR700 and incubated for 6hr. 1 hr after NIR irradiation, FACS analysis with PI staining was performed (n = 4, *p < 0.0001, **p = ns, Student's t test). In vitro NIR-PIT was blocked with excess trastuzumab.
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In vivo IR700 fluorescence imaging in response to repeated NIR-PIT.
In vivo IR700 fluorescence imaging in response to repeated NIR-PIT. IR700 fluorescence decreased after NIR-PIT in both models (A, flank model, B. pleural disseminated model).
